ZURICH (Reuters) - Alcon, the attention care company being spun-off through Novartis, might be protected in the Swiss Market Index of Switzerland's 20 biggest listed corporations, market operator SIX talked about on Tuesday.
suggestions about another adjustments to SMI and Switzerland's other indexes could be launched later, the bourse said.
Novartis last year introduced the spin off of Alcon to the Basel drugmaker's shareholders in the first half of this year.
bank Vontobel analysts have noted Alcon may be worth between $15 billion and $23 billion, including its ongoing restoration would affect the ultimate fee.
(Reporting by means of John Revill; modifying by means of Edmund Blair)
0 comentários:
Postar um comentário